OLD: Cafepharma Detail Piece Daily Pharma Headlines Archive for April, 2014

IMPORTANT: On Sunday, April 22, we send out an email with some important changes to our newsletter service. Please make sure you read this email, or the details on our our newsletter page, as our newsletter service changes will be taking effect on Monday, May 7, 2018.  On that date, your current newsletter subscription will end if you have not subscribed under our new plan. 

Click a link below to view the mailing archive as if it had been sent to you.

2014-04-29 08:20Cafepharma Detail Piece Daily Pharma Headlines List
2014-04-27 00:15Gardasil Vaccine Likely To Be Biggest Medical Scandal Of All Time â?Ç?ô According To Former Merck Doctor
2014-04-26 12:15AstraZeneca vulnerable after recent rumours and more...
2014-04-26 00:15Mylan Said to Raise Offer for Swedish Drugmaker Meda and more...
2014-04-25 12:15EU agency backs GSK melanoma drug, wider use of Bayer's Nexavar and more...
2014-04-25 00:15Alexion Posts Strong Earnings in Q1 and more...
2014-04-24 12:15Celgene profit down but tops expectations; keeps forecast and more...
2014-04-24 00:15Big Pharma sees danger, not safety, in FDA's new social media guidance and more...
2014-04-23 12:15Should Amgen Break Itself Up? and more...
2014-04-23 00:15Amgen Falls as Earnings, Revenue Disappoint and more...
2014-04-22 12:15GlaxoSmithKline CEO says established products portfolio "not part of our future" and more...
2014-04-22 00:15Billionaire Bill Ackman, Valeant Want To Takeover Botox-Maker Allergan and more...
2014-04-21 12:15Today's Market: Other Potential Buyout Targets For Pfizer and more...
2014-04-20 12:15NJ biotech firm develops 'female Viagra' for women with low sexual desire and more...
2014-04-20 00:15Flamel Technologies: Great Buying Opportunity Before Earnings Inflection
2014-04-19 12:15AbbVie urges U.S. court to avoid gay rights issue in HIV drug case and more...
2014-04-19 00:15In Case You Missed It: GlaxoSmithKline Just Had a Phenomenal Week! and more...
2014-04-18 12:15FDA wants stronger warning labels for long-acting opioids and more...
2014-04-18 00:15Johnson & Johnson's 3 Major Strengths and more...
2014-04-17 12:15Top 10 Pharma M&A deals of 2013 and more...
2014-04-17 00:15Gilead Sciences May See A Healthy Earnings Beat and more...
2014-04-16 12:15Rumor Mill: Is Google working on contact lenses for the blind? and more...
2014-04-16 00:15Eli Lilly/ Boehringer Drug Under FDA Review and more...
2014-04-15 12:15Angion swings for a $36M IPO as biotech's bear turn drags on and more...
2014-04-15 00:15Merck bags FDA approval for its grass pollen pill and more...
2014-04-14 12:15NeoStem Announces Definitive Agreement to Acquire California Stem Cell, Inc. and more...
2014-04-07 12:15Puma drug better than Herceptin in HER2 breast cancers -trial and more...
2014-04-06 12:15Pfizer Breast Cancer Drug Results "As Impressive As I've Ever Seen," Researcher Says and more...
2014-04-06 00:15Kaleoâ?Ç?Ös Evzio gets US FDA approval for treatment of opioid overdose
2014-04-05 12:15Supreme Court Studies Generic Drug Question: How Will Patients Fare? and more...
2014-04-04 12:15States revolt against powerful new painkiller and more...
2014-04-04 00:15Will Pfizer Unveil A Breast Cancer Blockbuster This Sunday? and more...
2014-04-03 12:15Is an Ariad Pharmaceuticals, Inc. Acquisition Realistic? and more...
2014-04-03 00:15GlaxoSmithKline yanks Paxil batches after FDA warning letter and more...
2014-04-02 12:15FDA defends generic drug label proposal at U.S. House hearing and more...
2014-04-02 00:15Stallergenes gains U.S. FDA approval for Oralair allergy drug and more...
2014-04-01 12:15The Hunt For Hidden Value: Gilead Gilded In Gold and more...
2014-04-01 00:15Can Arena and VIVUS Profit From Glaxo's Troubles? and more...

 

<< Archive IndexSubscribe >>

Contact Us

Past Issues

Unsubscribe